ESTIMATING THE POTENTIAL COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS (HPV) VACCINATION IN GERMANY USING A DYNAMIC TRANSMISSION MODEL

被引：0
|
作者：
Damm, O. [1 ]
Horn, J. [2 ]
Kretzschmar, M. [3 ]
Delere, Y. [4 ]
Kaufmann, A. M. [5 ]
Wichmann, O. [4 ]
Kraemer, A. [1 ]
Greiner, W. [1 ]
Mikolajczyk, R. [2 ]
机构：
[1] Univ Bielefeld, Sch Publ Hlth, D-33615 Bielefeld, Germany
[2] Bremen Inst Prevent Res & Social Med, Bremen, Germany
[3] Univ Med Ctr Utrecht, Utrecht, Netherlands
[4] Robert Koch Inst, Berlin, Germany
[5] Charite, D-13353 Berlin, Germany
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1199
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A452 / A452
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF QUADRIVALENT HPV VACCINATION IN GERMANY USING A DYNAMIC TRANSMISSION MODEL
    Schobert, D.
    Remy, V
    Schoeffski, O.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A273 - A273
  • [2] Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
    Schobert, Deniz
    Remy, Vanessa
    Schoeffski, Oliver
    [J]. HEALTH ECONOMICS REVIEW, 2012, 2
  • [3] Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
    Deniz Schobert
    Vanessa Remy
    Oliver Schoeffski
    [J]. Health Economics Review, 2 (1)
  • [4] Cost-effectiveness of quadrivalent human papillomavirus (HPV) vaccination in Mexico: A transmission dynamic model-based evaluation
    Insinga, Ralph P.
    Dasbach, Erik J.
    Elbasha, Elamin H.
    Puig, Andrea
    Myriam Reynales-Shigematsu, Luz
    [J]. VACCINE, 2007, 26 (01) : 128 - 139
  • [5] Cost-effectiveness of human papillomavirus vaccination in Germany
    Damm, Oliver
    Horn, Johannes
    Mikolajczyk, Rafael T.
    Kretzschmar, Mirjam E. E.
    Kaufmann, Andreas M.
    Delere, Yvonne
    Ultsch, Bernhard
    Wichmann, Ole
    Kraemer, Alexander
    Greiner, Wolfgang
    [J]. COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2017, 15
  • [6] Cost-effectiveness of human papillomavirus vaccination in Germany
    Oliver Damm
    Johannes Horn
    Rafael T. Mikolajczyk
    Mirjam E. E. Kretzschmar
    Andreas M. Kaufmann
    Yvonne Deleré
    Bernhard Ultsch
    Ole Wichmann
    Alexander Krämer
    Wolfgang Greiner
    [J]. Cost Effectiveness and Resource Allocation, 15
  • [7] Human papillomavirus transmission and cost-effectiveness of introducing quadrivalent HPV vaccination in Denmark
    Olsen, Jens
    Jepsen, Martin Rudbeck
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (02) : 183 - 191
  • [8] Potential health impact and cost-effectiveness of bivalent human papillomavirus (HPV) vaccination in Afghanistan
    Anwari, Palwasha
    Debellut, Frederic
    Vodicka, Elisabeth
    Clark, Andrew
    Farewar, Farhad
    Zhwak, Zubiada A.
    Nazary, Dastagger
    Pecenka, Clint
    LaMontagne, D. Scott
    Safi, Najibullah
    [J]. VACCINE, 2020, 38 (06) : 1352 - 1362
  • [9] Using a Dynamic Model to Estimate the Cost-Effectiveness of HPV Vaccination in Iran
    Hagens, Arnold
    Sloof, Albertus Constantijn
    Janghorban, Roksana
    [J]. VACCINES, 2024, 12 (04)
  • [10] Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
    Drolet, Melanie
    Laprise, Jean-Francois
    Boily, Marie-Claude
    Franco, Eduardo L.
    Brisson, Marc
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) : 2264 - 2268
12345